BIOMAT Database Logo BIOMAT Database Logo

Oral mucositis and salivary methotrexate concentration in intermediate-dose methotrexate therapy for children with acute lymphoblastic leukemia. 1989

E Ishii, and S Yamada, and S Higuchi, and T Honjo, and H Igarashi, and S Kanemitsu, and T Kai, and K Ueda
Department of Pediatrics, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

The relationship between salivary methotrexate (MTX) concentration and severity of oral mucositis after administration of MTX was investigated in six children with acute lymphoblastic leukemia. They received two administrations of MTX at 500 mg/m2 with one third given bolusly and the remainder by 24-hour continuous infusion. No significant difference among patients or administration session was observed in serum MTX concentration. Detectable concentrations of salivary MTX (greater than 0.01 microM) were observed during nine of the ten infusions. A concentration of 0.1 microM or more, apparently lasting at least 12 hours, was observed during one infusion and followed by severe mucositis. During two of the ten infusions for different patients, concentrations of 0.04 to 0.07 microM and 0.02 to 0.04 microM, apparently lasting at least 12 and 18 hours, respectively, were observed, followed by moderate mucositis. During the other seven infusions, either much shorter or no increase in salivary MTX concentration was observed, with only mild or no subsequent mucositis. Analysis by Kendall's rank method showed a statistical correlation between concentration at 6 hours of infusion and severity of oral mucositis. The findings suggest that the early secretion of MTX into saliva has a significant role in the development of oral mucositis in leukemic children.

UI MeSH Term Description Entries
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D009061 Mouth Mucosa Lining of the ORAL CAVITY, including mucosa on the GUMS; the PALATE; the LIP; the CHEEK; floor of the mouth; and other structures. The mucosa is generally a nonkeratinized stratified squamous EPITHELIUM covering muscle, bone, or glands but can show varying degree of keratinization at specific locations. Buccal Mucosa,Oral Mucosa,Mucosa, Mouth,Mucosa, Oral
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas
D013223 Statistics as Topic Works about the science and art of collecting, summarizing, and analyzing data that are subject to random variation. Area Analysis,Estimation Technics,Estimation Techniques,Indirect Estimation Technics,Indirect Estimation Techniques,Multiple Classification Analysis,Service Statistics,Statistical Study,Statistics, Service,Tables and Charts as Topic,Analyses, Area,Analyses, Multiple Classification,Area Analyses,Classification Analyses, Multiple,Classification Analysis, Multiple,Estimation Technic, Indirect,Estimation Technics, Indirect,Estimation Technique,Estimation Technique, Indirect,Estimation Techniques, Indirect,Indirect Estimation Technic,Indirect Estimation Technique,Multiple Classification Analyses,Statistical Studies,Studies, Statistical,Study, Statistical,Technic, Indirect Estimation,Technics, Estimation,Technics, Indirect Estimation,Technique, Estimation,Technique, Indirect Estimation,Techniques, Estimation,Techniques, Indirect Estimation
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

E Ishii, and S Yamada, and S Higuchi, and T Honjo, and H Igarashi, and S Kanemitsu, and T Kai, and K Ueda
Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia.
November 2008, International journal of clinical pharmacology and therapeutics,
E Ishii, and S Yamada, and S Higuchi, and T Honjo, and H Igarashi, and S Kanemitsu, and T Kai, and K Ueda
Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
January 2018, PloS one,
E Ishii, and S Yamada, and S Higuchi, and T Honjo, and H Igarashi, and S Kanemitsu, and T Kai, and K Ueda
Effectiveness of Parenteral Glutamine on Methotrexate-induced Oral Mucositis in Children with Acute Lymphoblastic Leukemia.
July 2017, Nutrition and cancer,
E Ishii, and S Yamada, and S Higuchi, and T Honjo, and H Igarashi, and S Kanemitsu, and T Kai, and K Ueda
Oral mucositis in children with acute lymphoblastic leukemia after high-dose methotrexate treatment without delayed elimination of methotrexate: relation to pharmacokinetic parameters of methotrexate.
January 1996, Pediatric hematology and oncology,
E Ishii, and S Yamada, and S Higuchi, and T Honjo, and H Igarashi, and S Kanemitsu, and T Kai, and K Ueda
High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia.
March 2008, Blood,
E Ishii, and S Yamada, and S Higuchi, and T Honjo, and H Igarashi, and S Kanemitsu, and T Kai, and K Ueda
Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
July 1996, Medical and pediatric oncology,
E Ishii, and S Yamada, and S Higuchi, and T Honjo, and H Igarashi, and S Kanemitsu, and T Kai, and K Ueda
Monitoring of methotrexate and 7-hydroxymethotrexate in saliva from children with acute lymphoblastic leukemia receiving high-dose consolidation treatment: relation to oral mucositis.
February 1997, Anti-cancer drugs,
E Ishii, and S Yamada, and S Higuchi, and T Honjo, and H Igarashi, and S Kanemitsu, and T Kai, and K Ueda
Methotrexate and its polyglutamate derivatives in erythrocytes during and after weekly low-dose oral methotrexate therapy of children with acute lymphoblastic leukemia.
January 1988, Cancer chemotherapy and pharmacology,
E Ishii, and S Yamada, and S Higuchi, and T Honjo, and H Igarashi, and S Kanemitsu, and T Kai, and K Ueda
A decrease in vitamin D levels is associated with methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
January 2019, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer,
E Ishii, and S Yamada, and S Higuchi, and T Honjo, and H Igarashi, and S Kanemitsu, and T Kai, and K Ueda
Disposition of intermediate-dose methotrexate in children with acute lymphocytic leukemia.
November 1982, Drug intelligence & clinical pharmacy,
Copied contents to your clipboard!